Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy. 

Accept / Decline


Inflammatory Bowel Disease Treatment Gets Boost From New Educational Resource. Elsevier, the journal Digestive Inflammatory and Ferring Pharmaceuticals announce the launch of the Inflammatory Bowel Disease Resource.

Saint-Prex, Switzerland / Amsterdam, The Netherlands, 22 April 2015 – A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre (www.IBD-RC.com) was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals. The Inflammatory Bowel Disease is a free online platform designed to increase healthcare professionals’ knowledge of IBD.

Click here to read more

See more Newsroom


Ferring Canada
200 Yorkland Boulevard, Suite 500
Toronto, Ontario, M2J 5C1 

Tel:  +1 416 490 0121 or +1 800 263 4057
Fax: 416 493 1692